| Date Filed | Type | Description |
| 02/14/2014 |
10-Q
| Quarterly Report for the period ended December 31, 2013 |
| 12/27/2013 |
10-K
| Annual Report for the period ended September 30, 2013 |
| 12/05/2013 |
8-K
| Quarterly results |
| 08/14/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 07/30/2013 |
SC 13D
| OSMAN RONALD E reports a 26% stake in Biovest International Inc. |
| 07/29/2013 |
SC 13D
| Valens Offshore SPV I, Ltd. reports a 62.7% stake in BIOVEST INTERNATIONAL, INC. |
| 07/22/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/15/2013 |
8-K
| Form 8-K - Current report |
| 05/15/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 03/07/2013 |
8-K
| Bankruptcy or Receivership, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer... |
| 02/22/2013 |
RW
| Form RW - Registration Withdrawal Request |
| 02/15/2013 |
10-Q
| Quarterly Report for the period ended December 31, 2012 |
| 02/14/2013 |
SC 13G/A
| LAURUS MASTER FUND LTD reports a 10.1% stake in BIOVEST INTERNATIONAL, INC. |
| 12/26/2012 |
10-K
| Annual Report for the period ended September 30, 2012 |
| 11/23/2012 |
8-K
| Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an... |
| 10/15/2012 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant |
| 08/14/2012 |
10-Q
| Quarterly Report for the period ended June 30, 2012 |
| 08/14/2012 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 06/12/2012 |
8-K
| Form 8-K - Current report |
| 06/07/2012 |
8-K
| Investor presentation |
| 05/31/2012 |
8-K
| Investor presentation|
Docs:
|
"Biovest Interviewed by OneMedRadio; Discusses Key Milestones Expected to Establish BiovaxID ® as the World's First Personalized Cancer Vaccine for the Treatment of Non-Hodgkin's Lymphoma TAMPA, FL and MINNEAPOLIS, MN - May 31, 2012 - Biovest International, Inc. , a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. , today announced that Brett Johnson, President and Executive Editor of OneMedPlace interviewed Biovest's President and CEO, Samuel S. Duffey, and its Senior Vice President, Product Development & Regulatory Affairs, Carlos F. Santos, Ph.D. In the webcast audio interview on OneMedRadio, Biovest discussed its global regulatory strategy for BiovaxID ® , Biovest's personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, including plans to file ...",
"A PowerPoint presentation, portions of which are incorporated in the video presentation of the Biovest Interview by OneMedRadio referenced in attached hereto and which may be used from time to time in presentations to various third parties" |
|
| 05/15/2012 |
10-Q
| Quarterly Report for the period ended March 31, 2012 |
| 05/14/2012 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"Biovest to Seek Marketing Approval in the EU for BiovaxID ® Personalized Lymphoma Cancer Vaccine TAMPA, FL and MINNEAPOLIS, MN - May 14, 2012 - Biovest International, Inc. , a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. , today announced that Biovest plans to file for marketing approval in the European Union for BiovaxID ® , its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system. Biovest plans to file a Marketing Authorization Application , with the European Medicines Agency , the Agency responsible for the scientific evaluation of applications for the EU under the centralized procedure. EMA approval would establish BiovaxID as the first cancer vaccine available in Europe for lymphoma patients. Bio..." |
|
| 04/23/2012 |
8-K
| Form 8-K - Current report |
| 04/19/2012 |
8-K
| Investor presentation |
| 04/18/2012 |
144
| Form 144 - Report of proposed sale of securities |
| 04/18/2012 |
144
| Form 144 - Report of proposed sale of securities |
| 04/18/2012 |
144
| Form 144 - Report of proposed sale of securities |
| 04/18/2012 |
144
| Form 144 - Report of proposed sale of securities |
| 04/10/2012 |
8-K
| Form 8-K - Current report |
| 04/03/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/30/2012 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 03/08/2012 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 02/10/2012 |
10-Q
| Quarterly Report for the period ended December 31, 2011 |
|